Legend Biotech (LEGN) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free LEGN Stock Alerts $46.19 -0.93 (-1.97%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFederated Hermes Inc. Decreases Position in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - April 19 at 8:27 AMHC Wainwright Weighs in on Legend Biotech Co.'s Q3 2024 Earnings (NASDAQ:LEGN)americanbankingnews.com - April 19 at 2:31 AMScotiabank Upgrades Legend Biotech (NASDAQ:LEGN) to "Sector Outperform"americanbankingnews.com - April 19 at 1:44 AMQ3 2024 EPS Estimates for Legend Biotech Co. Lifted by HC Wainwright (NASDAQ:LEGN)marketbeat.com - April 18 at 6:16 AMLegend Biotech (NASDAQ:LEGN) Reaches New 1-Year Low at $49.13americanbankingnews.com - April 18 at 4:50 AMQ1 2024 Earnings Forecast for Legend Biotech Co. (NASDAQ:LEGN) Issued By HC Wainwrightamericanbankingnews.com - April 18 at 1:28 AMScotiabank upgrades Legend Biotech to sector outperformseekingalpha.com - April 17 at 6:01 PMLegend Biotech Co. (NASDAQ:LEGN) to Post Q1 2024 Earnings of ($0.01) Per Share, HC Wainwright Forecastsmarketbeat.com - April 17 at 4:48 PMLegend Biotech (NASDAQ:LEGN) Raised to "Sector Outperform" at Scotiabankmarketbeat.com - April 17 at 3:50 PMLegend Biotech (NASDAQ:LEGN) Shares Gap Up to $50.12marketbeat.com - April 17 at 10:52 AMMirae Asset Global Investments Co. Ltd. Purchases New Stake in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - April 17 at 4:51 AMLegend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC Wainwrightamericanbankingnews.com - April 17 at 4:10 AMBuy Rating Affirmed for Legend Biotech Amidst Anticipated Growth and Expanded Carvykti Usemarkets.businessinsider.com - April 17 at 1:56 AMBuy Rating Affirmed for Legend Biotech Amidst Growth Prospects and CARVYKTI’s Market Expansionmarkets.businessinsider.com - April 16 at 8:55 PMHC Wainwright Reaffirms "Buy" Rating for Legend Biotech (NASDAQ:LEGN)marketbeat.com - April 16 at 1:27 PMLegend Biotech (NASDAQ:LEGN) Sets New 1-Year Low at $49.13marketbeat.com - April 16 at 11:03 AMLEGN Quantitative Stock Analysisnasdaq.com - April 14 at 7:33 PMLegend Biotech is Now Oversold (LEGN)nasdaq.com - April 14 at 12:21 AMLegend Biotech to Host Investor Conference Call on First Quarter 2024 Resultsbusinesswire.com - April 11 at 8:00 AMQ2 2024 EPS Estimates for Legend Biotech Co. Decreased by HC Wainwright (NASDAQ:LEGN)americanbankingnews.com - April 11 at 1:18 AMQ2 2024 EPS Estimates for Legend Biotech Co. (NASDAQ:LEGN) Cut by HC Wainwrightmarketbeat.com - April 10 at 8:13 AMQ1 2024 Earnings Estimate for Legend Biotech Co. (NASDAQ:LEGN) Issued By HC Wainwrightamericanbankingnews.com - April 10 at 1:22 AMQ1 2024 Earnings Forecast for Legend Biotech Co. Issued By HC Wainwright (NASDAQ:LEGN)marketbeat.com - April 9 at 6:09 AMLegend Biotech Co. (NASDAQ:LEGN) Receives Average Recommendation of "Moderate Buy" from Brokeragesamericanbankingnews.com - April 9 at 4:42 AMLegend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 9 at 4:41 AMAnalysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX), Legend Biotech (LEGN) and Intellia Therapeutics (NTLA)markets.businessinsider.com - April 9 at 1:28 AMBuy Rating on Legend Biotech: FDA Approval and Market Potential Bolster Carvykti’s Outlookmarkets.businessinsider.com - April 7 at 6:54 PMLegend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myelomafinance.yahoo.com - April 6 at 3:11 AMLegend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myelomabusinesswire.com - April 5 at 11:30 PMShould You Continue to Hold Legend Biotech Corporation (LEGN)?finance.yahoo.com - April 3 at 9:05 AMCantor Fitzgerald Begins Coverage on Legend Biotech (NASDAQ:LEGN)marketbeat.com - April 3 at 7:31 AMAnalysts Are Bullish on These Healthcare Stocks: Shockwave Medical (SWAV), Veeva Systems (VEEV)markets.businessinsider.com - April 2 at 12:57 PMNatera and Alliance for Clinical Trials in Oncology announce activation of mid-stage trial in urothelial cancerseekingalpha.com - April 1 at 4:55 PMLegend Biotech (NASDAQ:LEGN) Rating Reiterated by HC Wainwrightmarketbeat.com - April 1 at 8:30 AMStock market bubble warnings are everywhere. These are the 10 most richly valued stocks right now.msn.com - March 31 at 8:40 AMManagement’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4finance.yahoo.com - March 29 at 10:16 AMLegend Biotech (NASDAQ:LEGN) Stock Price Down 2.1%marketbeat.com - March 28 at 4:33 PMLegend Biotech Co. (NASDAQ:LEGN) is Matthews International Capital Management LLC's 5th Largest Positionmarketbeat.com - March 25 at 4:22 PMAnalysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Legend Biotech (LEGN)markets.businessinsider.com - March 24 at 10:10 AMDeutsche Bank AG Has $7.10 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - March 22 at 4:11 AMGenScript Losses Shrink On Strong Growth For Cancer Cell Therapybenzinga.com - March 20 at 7:36 PMLegend Biotech (NASDAQ:LEGN) Stock Price Down 5%marketbeat.com - March 19 at 3:09 PMLegend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Reportfinance.yahoo.com - March 19 at 1:03 PMLegend Biotech's (LEGN) Buy Rating Reiterated at HC Wainwrightmarketbeat.com - March 18 at 5:32 PMLegend Biotech (NASDAQ:LEGN) PT Raised to $81.00marketbeat.com - March 18 at 2:53 PMWellington Management Group LLP Has $90.28 Million Stock Holdings in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - March 18 at 4:54 AMAnalysts Issue Forecasts for Legend Biotech Co.'s Q1 2025 Earnings (NASDAQ:LEGN)marketbeat.com - March 18 at 2:27 AMGuru Fundamental Report for LEGNnasdaq.com - March 16 at 5:11 PMJohnson & Johnson wins FDA AdCom backing for Carvykti label expansionmsn.com - March 15 at 4:07 PMCARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myelomabusinesswire.com - March 15 at 3:15 PM Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! LEGN Media Mentions By Week LEGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼0.260.52▲Average Medical News Sentiment LEGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼254▲LEGN Articles Average Week Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ASND News CTLT News ITCI News CERE News VKTX News UTHR News SRPT News CYTK News JAZZ News ELAN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.